Direxion Daily S&P Biotech Bull 3X Shares LABU
237.35 USD -7.76 (-3.17%)
Nov 10, 2026, 3:55 PM EST
227.17 Day range 249.60
119.38 52-week range 341.93
- YTD
- +48.91%
- 1 year
- +95.53%
- Market cap
- 1.31B
- YTD return
- +48.91%
- 1-year return
- +95.53%
- Volume
- 281.16K
- Avg volume
- 390.26K
- Open
- 237.59
- Previous close
- 245.11
- Day's range
- 227.17 – 249.60
- 52-week range
- 119.38 – 341.93
5D -14.82 (-5.87%)
Key statistics
- Enterprise value
- 0
- PEG ratio
- 0.00
- Price / sales
- 0.00
- Price / book
- 0.00
- Dividend yield
- 0.00%
- Payout ratio
- 0.00%
- Revenue growth
- 0.00%
- Free cash flow
- 0
- Total cash
- 0
- Total debt
- 0
- Return on equity
- 0.00%
- Short % of float
- 0.00%
- 50-day average
- 251.97
- 200-day average
- 217.94
Next earnings
Consensus EPS estimate 0.00.
About Direxion Daily S&P Biotech Bull 3X Shares
The fund, under normal circumstances, invests at least 80% of its net assets in financial instruments, such as swap agreements, securities of the index, and ETFs that track the index, that, in combination, provide 3X daily leveraged exposure to the index, consistent with the fund's investment objective. The index is designed to measure the performance of the biotechnology sub-industry based on the Global Industry Classification Standards ("GICS"). The fund is non-diversified.
News
EXCLUSIVE: Beyond The Magnificent Seven — Direxion's Egilinsky Reveals Top Sector Picks 
Market Momentum: Your Weekly Financial Forecast - These Are The Leveraged ETFs At Play When Trade War Worries Strike
Pharma Catches Another Case Of M&A Fever 
Exploring The Leveraged ETF Trade Heading Into Earnings Season 
As The Market Scrambles Over Tech And Trade Fears, ETF Fund Flow Signals Interesting Rotation 
CUREs For The Ordinary December Trade 
Heaps Of Healthy Health Care ETFs - Which Leveraged ETFs Will Be Hot This Week?
How Volatility Affects 2 Popular Leveraged ETFs
Your note
Sign in to keep a note on LABU — it syncs with the Stock Master app.